Hyper IgM Foundation Competitors

The LLS mission: Cure leukemia, lymphoma, Hodgkin’s disease and myeloma, and improve the quality of life of patients and their families. LLS funds lifesaving blood cancer research around the world and provides free information and support services. The Mid-Atlantic Region of LLS serves the Northern Virginia, Maryland, and Washington, DC Metropolitan area. We provide patient support groups, education programs, financial aid and co-pay assistance for patients in our area.

For the thousands of people diagnosed every year with life-threatening blood cancers like leukemia and lymphoma, a cure exists. Over the past 30 years Be The Match®, operated by the National Marrow Donor Program® (NMDP), has managed the largest and most diverse blood stem cell registry in the world. We work every day to save lives through cellular therapy. To work with us is to be an integral part of our life-saving mission. We are committed to providing challenging, meaningful opportunities in support of employee growth and development. We are an organization of compassionate people, working with cutting-edge technology and innovative science. As an employer of choice, we value diversity, embrace learning and live our core values. Learn more about our career opportunities at BeTheMatch.org/careers.

The National Organization for Rare Disorders (NORD), a 501(c)(3) organization, is an independent patient advocacy organization dedicated to helping individuals with rare diseases and the organizations that serve them. NORD, along with its 350+ patient organization members, is committed to the identification, treatment, and cure of rare disorders through programs of education, advocacy, research, and patient support services. NORD serves all stakeholders in the rare disease community, including patients and their families, patient organizations, researchers, medical professionals, medical students, and companies developing orphan products. NORD also works closely with many government agencies, most notably the National Institutes of Health (NIH) and the Food and Drug Administration (FDA). All NORD programs are focused on one ultimate goal: to improve the lives of individuals and families affected by rare diseases. NORD is the official U.S. sponsor of Rare Disease Day, an international observance day held on the last day of February each year. Its goals are to raise awareness for rare diseases and improve access to treatment and medical representation for individuals with rare diseases and their families. To learn more, visit rarediseases.org/rare-disease-day. To learn more, please visit the NORD website at www.rarediseases.org. You can also follow NORD on X at @RareDiseases.